Female PIs remain underrepresented in cardiovascular clinical trials despite decade of efforts

Women with heart disease may receive less accurate clinical guidance due to underrepresentation in trials, as women often experience atypical symptoms that differ from male presentations.

For a decade, the cardiovascular research community pledged to open its doors more widely to women — yet when the numbers were finally counted across 620 clinical trials, barely one in five was led by a female investigator. Researchers at UC Berkeley, presenting at the American College of Cardiology's 2022 annual session, found that this imbalance is not merely a matter of professional equity but of medical consequence: women experience heart disease differently, and trials shaped predominantly by and around men may be quietly failing them. The structures that sustain this disparity — particul

Female PIs remain underrepresented in cardiovascular clinical trials despite decade of efforts

Cobertura Relacionada

Receba o Register no seu e-mail